VJHemOnc is committed to improving our service to you

VJVirtual | Applying molecular understanding of DLBCL to management strategies

VJHemOnc is committed to improving our service to you

Andrew Davies

Andrew Davies MRCP, PhD, University of Southampton, Southampton, UK outlines the utility of molecular profiling for the classification of diffuse large B-cell lymphoma (DLBCL) subtypes and subsequently, how this can be applied in treatment as therapeutic targeting of specific oncogenic abberations.This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter